The Converge Advisory Group serves as trusted and unbiased advisors by focusing exclusively on helping our clients bring innovative medicines to
market faster and with a greater probability of success.
We apply a broad and deep understanding of drug development and commercialization, based on 40+ years of combined experience, to help clients improve
pipeline productivity throughout the lifecycle with strategic and operational support.
We employ a unique and innovative consulting approach that leverages large
and un-biased evidence-based strategies and flexible project delivery models.
We design higher quality strategies faster than our competition by applying our
combined 40+ years of experience, a machine-learning platform, and proven methodologies and tool sets.